decisionhealth Newsletters, Answer Books - 2008 Issue 12 (December)
Physician_Fee_Schedule_Rules / Copy of 151-200
Subscribe or sign in to view the full article.
Article Overview
This page is part of a Medicare physician fee schedule rules discussion focused on end-stage renal disease payment policy. It covers projected dialysis treatment volume, estimated drug spending, budget-neutrality calculations, and the development and review of patient characteristic adjustments for a case-mix payment system. The content is useful for coders, compliance staff, dialysis facilities, and reimbursement professionals who need to understand the scope of the policy discussion and the types of operational data and adjustment factors addressed in the rulemaking.
Why This Topic Matters
The article helps readers identify whether the full premium content is relevant to ESRD reimbursement, facility payment methodology, and case-mix adjustment policy. It is especially useful for teams tracking Medicare payment rule updates and the administrative data considerations behind those updates.
Article Sections
-
III. Dialysis Treatments
Discusses projected dialysis treatment volume and the data basis for the estimate. The section addresses utilization trends in ESRD beneficiaries and treatment counts.
-
IV. Estimated Drug Spending
Reviews updated spending estimates for ESRD-related drugs and related payment assumptions. The section describes how aggregate spending projections were adjusted for different facility types.
-
V. Add-On Calculation and Budget Neutrality
Explains the budget-neutrality framework used to estimate an add-on adjustment for ESRD composite payment rates. It also transitions into the patient characteristic adjustment discussion.
-
A. Patient Characteristic Adjustments
Introduces the case-mix adjustment discussion for ESRD payment policy. The section covers the policy background and the categories of patient characteristics considered.
-
1. Sample Data Used to Develop the Basic Case-Mix System
Addresses comments and responses about the data source, sample selection, and timing of the information used to develop the adjustment methodology. It also discusses facility data availability and study sample composition.
-
2. Including Co-morbid Conditions in the Case-mix Adjustment
Discusses comments and responses concerning the inclusion of co-morbid conditions in the case-mix methodology. The section also covers related reporting and data-quality concerns.
What You Will Learn
- The general structure of the ESRD payment policy discussion in the article
- How the article frames dialysis treatment projections and drug spending estimates
- What kinds of budget-neutrality and add-on calculation topics are addressed
- How the article approaches patient characteristic and case-mix adjustment issues
- What data and reporting concerns are discussed in the context of ESRD payment methodology
Who Should Read This
- Medical coders
- Dialysis facility billing staff
- Revenue cycle professionals
- Compliance teams
- Medicare reimbursement analysts
- Healthcare consultants
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com